LHC Group (NASDAQ:LHCG) will be issuing its quarterly earnings data after the market closes on Wednesday, August 7th. Analysts expect the company to announce earnings of $1.00 per share for the quarter. LHC Group has set its FY 2019 guidance at $4.25-4.35 EPS and its FY19 guidance at $4.25-$4.35 EPS.Parties interested in registering for the company’s conference call can do so using this link.
LHC Group (NASDAQ:LHCG) last released its quarterly earnings results on Wednesday, May 8th. The health services provider reported $0.98 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.08. LHC Group had a return on equity of 8.43% and a net margin of 3.83%. The company had revenue of $502.59 million during the quarter, compared to analysts’ expectations of $511.16 million. On average, analysts expect LHC Group to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.
LHC Group stock opened at $120.23 on Tuesday. The company has a 50-day simple moving average of $121.28. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.57 and a current ratio of 1.57. LHC Group has a one year low of $80.84 and a one year high of $129.37. The stock has a market capitalization of $3.89 billion, a PE ratio of 33.87, a PEG ratio of 2.10 and a beta of 0.84.
LHCG has been the subject of a number of research analyst reports. BidaskClub upgraded LHC Group from a “buy” rating to a “strong-buy” rating in a research note on Friday. Royal Bank of Canada increased their price target on LHC Group to $130.00 and gave the company an “outperform” rating in a research note on Monday, May 13th. Jefferies Financial Group increased their price objective on LHC Group from $125.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, May 9th. Barclays reissued a “hold” rating on shares of LHC Group in a report on Sunday, May 12th. Finally, UBS Group set a $133.00 price objective on LHC Group and gave the company a “buy” rating in a report on Friday, May 10th. Three analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $122.70.
About LHC Group
LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.
Further Reading: What are catch-up contributions?
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.